Leonard Matthew J 4

What Happened Matthew J. Leonard, a director of ANI Pharmaceuticals, was granted 4,357 restricted shares on May 21, 2026. The award was reported as an acquisition at $0.00 per share (total reported value $0) and is recorded as a restricted stock award.

Key Details

• Transaction date: May 21, 2026. Filing date: June 10, 2026 (appears to be late relative to the 2-business-day Form 4 deadline).
• Security: 4,357 restricted shares granted (transaction code A — award/grant).
• Price: $0.00 per share; reported total $0.
• Vesting: Per footnote, the restricted stock award vests in full on May 21, 2027.
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1, tax-withholding, or sale noted in this filing.

Context This was a restricted stock grant (an acquisition via award), not an open-market purchase or sale. Restricted shares typically remain subject to vesting conditions — here, the shares vest in one year — and are commonly used for compensation or retention. The late filing may affect timeliness transparency but does not change the substance of the reported award.